RIVN
Rivian Automotive, Inc.
RIVN has the edge over SHOE overall, supported by stronger valuation and stronger modeled upside.
SHOE
Shoe Station Group Inc.
SHOE's outlook is improving despite an expensive valuation.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SHOE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
SHOE's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
SHOE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.3x | $5.57 | -61% |
| Fair | 9.2x | $8.12 | -43% |
| Forward | 10x | $14.20 | — |
| Expensive | 15x | $13.27 | -6.5% |
| Current | 16x | $14.20 | — |
Historical ranges are pointers, not guarantees.
SHOE's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over SHOE on the outlook, with more favorable revenue expectations.
SHOE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect SHOE's earnings to grow and its profitability to improve, with its revenue holding steady.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
SHOE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.39 | +58% |
| Q3 2026 | $0.88 | -61% |
| Q2 2026 | $1.35 | -44% |
| Q1 2026 | $1.90 | -29% |
| Q4 2025 | $2.10 | -23% |
| Q3 2025 | $2.27 | -20% |
| Q2 2025 | $2.39 | -12% |
| Q1 2025 | $2.68 | 0% |
| Q4 2024 | $2.72 | -6.2% |
SHOE has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over SHOE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
SHOE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $284.3M | -7.2% |
| Q2 2026 | $270.7M | -2.5% |
| Q1 2026 | $254.1M | -3.4% |
| Q4 2025 | $297.2M | -3.2% |
| Q3 2025 | $306.4M | -7.9% |
| Q2 2025 | $277.7M | -7.5% |
| Q1 2025 | $262.9M | -6.1% |
| Q4 2024 | $306.9M | -4.1% |
SHOE's revenue has slid since its 2021 peak: $284M last quarter, down 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | -5.6 points |
| Q2 2026 | -2.2% | -6.5 points |
| Q1 2026 | 4.3% | -1 points |
| Q4 2025 | 6.3% | -1.7 points |
| Q3 2025 | 8.2% | -0.8 points |
| Q2 2025 | 4.3% | -3.2 points |
| Q1 2025 | 5.3% | -1.8 points |
| Q4 2024 | 8% | -0.7 points |
SHOE has the edge over RIVN on profitability, with a higher operating margin.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
SHOE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +197% |
| Q2 2026 | $12.6M | +$35.6M |
| Q1 2026 | $27.7M | -24% |
| Q4 2025 | $19.7M | +138% |
| Q3 2025 | $2.2M | -88% |
| Q2 2025 | -$23M | -435% |
| Q1 2025 | $36.2M | -11% |
| Q4 2024 | $8.3M | -76% |
SHOE has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SHOE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
SHOE has more cash than debt.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
SHOE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 71.0 | Neutral |
SHOE's weekly RSI is 45 (neutral) and its Stochastic is 71 (neutral).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
SHOE PE vs Consumer Cyclical Sector
| Metric | SHOE | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 10% below |
| PE % | 85 | 47 | 38 pts above |
SHOE is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
SHOE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.7 | 3.6% above |
| 20 week MA | $14.2 | 0.1% below |
| 50 week MA | $16.6 | 14% below |
| 100 week MA | $19.2 | 26% below |
| 200 week MA | $24.7 | 42% below |
SHOE has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.
SHOE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.4 | +5.3% |
| 2021 | $19.4 | $39.3 | +102% |
| 2022 | $39.3 | $24.5 | -38% |
| 2023 | $24.5 | $30.2 | +23% |
| 2024 | $30.2 | $35.7 | +18% |
| 2025 | $35.7 | $18.1 | -49% |
| 2026 YTD | $18.1 | $14.2 | -21% |
SHOE has the edge over RIVN on returns for 2026, with the stronger performance.